跳转至内容
Merck

[History of the therapy of pernicious anemia].

Orvosi hetilap (2013-10-29)
András Jeney
摘要

Increased blood cell regeneration in exsanguinated experimental animals treated either with liver or with aqueous liver extracts was reported by Whipple and by Jeney and Jobling, respectively. These findings stimulated Minot and Murphy to provide evidence for the efficacy of liver against anaemia in clinical studies. After oral administration of liver (45-50 g per day) for 45 patients with anaemia perniciosa improvement of the hematological status was demonstrated. Consequently, for proving the therapeutic value of liver therapy Whipple, Minot and Murphy received Nobel price in 1934. The isolation of the antianemic factor from the liver has been succeeded in 1948 and designated as vitamin B12. At the same time Lucy Wills applied yeast for the treatment of pregnant women with anemia related to undernourishment. The conclusions of this study inspired the discovery of folate. The detailed investigation of the mode of action of vitamin B12 and folate enriched our knowledge in the area of pathophysiology and extended the clinical application of these two drugs.

材料
货号
品牌
产品描述

Sigma-Aldrich
维生素 B 12, ≥98%
Sigma-Aldrich
叶酸, ≥97%
Sigma-Aldrich
维生素 B 12, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
叶酸, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥97%
Supelco
腈钴胺(维生素 B12), analytical standard
Supelco
维生素B12标准液 CRM 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
维生素B12, pharmaceutical secondary standard, certified reference material
Supelco
叶酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
氰钴胺, meets USP testing specifications
Sigma-Aldrich
叶酸, meets USP testing specifications
叶酸, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
氰钴胺, tested according to Ph. Eur.